JPRN-UMIN000011865招募中未知
Efficacy of Aliskiren in hypertensive patients with diabetes mellitus or obesity - Efficacy of Aliskiren
Tokyo Women's Medical University0 个研究点目标入组 104 人开始时间: 2013年9月25日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 104
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. type I diabetes mellitus 2. HbA1c>9.0% 3. CKD group IV or higher 4. hyperkalemia 5. unstable angina pectoris 6. occurrence of acute myocardial infarction or stroke within 24 weeks 7. severe liver dysfunction 8. pregnancy or lactating women
研究者
相似试验
已完成
3 期
Clinical Study to Evaluate the Efficacy and Safety of Aliskiren Alone and in Combination With Hydrochlorothiazide in Patients With Essential Hypertension.HypertensionNCT00219024Novartis2,775
进行中（未招募）
不适用
The Effect Of Antihypertensive Treatment With Lisinopril and Labetalol on Baroreflex Sensitivity in Stroke - Effect Of Lisinopril and Labetalol On BRS In StrokeStrokeEUCTR2004-004231-53-GBRoyal Devon and Exeter NHS Foundation Trust23
已完成
不适用
The effect of antihypertensive treatment with Lisinopril and Labetalol on baroreflex sensitivity in strokeCardiovascular: StrokeCirculatory SystemStrokeISRCTN37578410Record Provided by the NHSTCT Register - 2005 Update - Department of Health23
已完成
不适用
Potency of antihypertensive therapy with Azilsartan on Walking Activity among Peripheral Artery Disease Patients With hypertention and Intermittent ClaudicatioPeripheral artery diseaseJPRN-UMIN000013670Sakakibara heart Institute14
未知
3 期
SPP100 (Aliskiren) regimen in hypertensive patients with renal dysfunctioHypertensionJPRN-jRCT2080220235ovartis Pharma K.K.38